Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2026-01-01 @ 4:17 PM
Study NCT ID:
NCT04776135
Status:
COMPLETED
Last Update Posted:
2024-01-08
First Post:
2021-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube
Sponsor:
Tanabe Pharma Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MT-1186-Z-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None